Aesthetic Medicine Market by Products (Body Contouring Devices, Cosmetic Implants, Facial Aesthetic Products), Type (Invasive Procedures, Non-Invasive Procedures), Gender, End-User - Global Forecast 2024-2030

Aesthetic Medicine Market by Products (Body Contouring Devices, Cosmetic Implants, Facial Aesthetic Products), Type (Invasive Procedures, Non-Invasive Procedures), Gender, End-User - Global Forecast 2024-2030

The Aesthetic Medicine Market size was estimated at USD 81.81 billion in 2023 and expected to reach USD 91.59 billion in 2024, at a CAGR 12.33% to reach USD 184.65 billion by 2030.

Aesthetic medicine, also known as cosmetic medicine, is a rapidly growing interdisciplinary field encompassing various medical practices to enhance the patient's appearance, self-esteem, and overall well-being through minimally invasive or non-invasive procedures. This specialized medical practice combines artistry with the latest scientific advancements to address an array of concerns related to aging, skin health, body contouring, and facial aesthetics. Technological advancements in cosmetic surgery equipment and techniques and increasing demand for non-invasive cosmetic procedures have accelerated the need for aesthetic medicines. However, limited reimbursement coverage and strict regulatory guidelines can act as barriers to increasing the use of these medicines. Advanced research in the field has led to the development of innovative aesthetic medicine products with improved safety profiles and minimal downtime post-procedure. Market players are working on integrating digital technologies such as telemedicine platforms or virtual consultations to help reach a wider audience while improving patient convenience.

Regional Insights

The Americas portrays a well-established aesthetic medicine market driven by the increased presence of well-known manufacturers, creating a competitive environment that fuels innovation and product development. Increased awareness about various non-surgical treatments, such as injectables and body contouring products in the U.S. and Canada, has accelerated the demand for aesthetic medicine in the region. In Asia-Pacific (APAC), the demand for aesthetic medicine is rapidly growing due to cultural factors such as beauty standards and increasing disposable incomes among middle-class populations. In particular, South Korean, Chinese, and Japanese consumers prioritize skincare products focusing on anti-aging benefits, creating an improved market for aesthetic medicine. Europe boasts a strong tradition of excellence in dermatology research, leading to innovations within aesthetic medicine over time. International medical tourism to countries such as Poland, Hungary, and the Czech Republic has expanded, where patients can access high-quality treatments at a lower cost. The European Medicines Agency (EMA) plays a crucial role in overseeing market authorization for aesthetic medicine products within the European Union.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Aesthetic Medicine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Increasing preference for minimally invasive reconstruction surgeries
• Proliferation in the number of congenital face disorders and breast deformities
• Growing consumer awareness about aesthetic appearance globally

Market Restraints

• High cost of the aesthetic treatments

Market Opportunities

• Technological advancements in aesthetic surgical procedures
• Introduction of advanced materials such as silicone implants in aesthetic surgery

Market Challenges

• Unfavorable reimbursement policies and stringent regulatory scenarios

Market Segmentation Analysis

• Products: Rising demand for cosmetic implants to improve aesthetic appearances
• End-User: Increasing number of aesthetic surgeries conducted across dermatology clinics and cosmetic centers

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Aesthetic Medicine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Aesthetic Medicine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

MedShift Launches SaaS Platform for Medical Aesthetic Businesses

MedShift has launched the Velocity Technology Suite, a Software-as-a-Service (SaaS) solution designed specifically for medical aesthetic businesses. This innovative platform enables sales acceleration and business automation, providing a range of capabilities such as eCommerce, digital order entry, sales territory mapping, and commission payout reporting.

ARCHIMED Buys WiQo, a Pioneer in the Field of Aesthetic Medicine

ARCHIMED, a healthcare specialist, has acquired WiQo, a leading European consumer health provider in the field of aesthetic medicine. This strategic acquisition of WiQo is set to drive further growth and innovation in aesthetic medicine, benefiting both healthcare professionals and patients.

Functionalab Completes Merger with FYi Medical Aesthetics, Creating the Largest Network of Premium Aesthetic Medicine Clinics in Canada

Functionalab Inc. and FYi Medical Aesthetics completed a merger, resulting in the establishment of the largest network of premium aesthetic medicine clinics in Canada. This merger enhances the company's business offerings in the Canada region.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Aesthetic Medicine Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alma Lasers Ltd. by Shanghai Fosun Pharmaceutica Group Co., Ltd., Bioxis Pharmaceuticals, Black & Black Surgical, Inc., BTL Industries, Candela Corporation, Cutera, Inc., Cynosure Inc., Cytrellis, Inc., Dimeda Instrumente GmBH, Fotona d.o.o., Galderma SA, Inmode Ltd., Johnson & Johnson Services Inc., KARL STORZ SE & Co. KG, Lumenis Be Ltd. by Boston Scientific Corp., Lutronic Inc., Lynton Lasers Ltd., Medytox Inc., Merz Pharma GmbH & Co. KGaA, Millennium Surgical Corp., miraDry, Inc., Quanta System S.p.A. by El.En. S.p.A., Sciton, Inc., Sientra, Inc., Sinclair Pharma Ltd., Solta Medical, Strata Skin Sciences, Venus Concept, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Products
• Body Contouring Devices
• Cellulite Reduction Devices
• Liposuction Devices
• Non-Surgical Fat Reduction Devices
• Cosmetic Implants
• Breast implants
• Facial implants
• Gluteal implants
• Facial Aesthetic Products
• Botulinum toxin
• Chemical peels
• Derma Fillers
• Microdermabrasion products
• Hair Removal Devices
• Nail Treatment Laser Devices
• Physician-Dispensed Eyelash Products
• Skin Aesthetic Devices
• Laser Skin Resurfacing Sevices
• Light Therapy Devices
• Microneedling Devices
• Non-surgical Skin Tightening Devices
• Tattoo Removal Devices
• Thread Lift Products
• Type
• Invasive Procedures
• Non-Invasive Procedures
• Gender
• Female
• Male
• End-User
• Ambulatory Surgical Center
• Beauty Center & Medical Spa
• Dermatology Clinic
• Home Setting
• Hospital
• Region
• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year